TABLE 2.
Rv2629 191A/C allele distribution
| Characteristica | Rv2629 191C [no. (%)] | Rv2629 191A [no. (%)] | P |
|---|---|---|---|
| RIF resistant | 30 (30.6) | 68 (69.4) | 0.011 |
| RIF susceptible | 25 (16.9) | 123 (83.1) | |
| INH resistant | 37 (29.8) | 87 (70.2) | 0.005 |
| INH susceptible | 18 (14.8) | 104 (85.2) | |
| EMB resistant | 21 (25.9) | 60 (74.1) | 0.347 |
| EMB susceptible | 34 (20.6) | 131 (79.4) | |
| STR resistant | 26 (27.1) | 70 (72.9) | 0.155 |
| STR susceptible | 29 (19.3) | 121 (80.7) | |
| Pansusceptible | 11 (13.3) | 72 (86.7) | 0.001 |
| Continent of origin | <0.001 | ||
| Asia | 40 (46.5) | 46 (53.5) | |
| Africa | 1 (2.0) | 50 (98.0) | |
| Europe | 1 (5.6) | 17 (94.4) | |
| North America | 4 (16.7) | 20 (83.3) | |
| South America | 5 (12.2) | 36 (87.8) | |
| Unknown | 4 (15.4) | 22 (84.6) | |
| SCG | <0.001 | ||
| 1 | 0 (0.0) | 23 (100.0) | |
| 2 | 55 (100.0) | 0 (0.0) | |
| 3a | 0 (0.0) | 11 (100.0) | |
| 3b | 0 (0.0) | 35 (100.0) | |
| 3c | 0 (0.0) | 7 (100.0) | |
| 4 | 0 (0.0) | 7 (100.0) | |
| 5 | 0 (0.0) | 83 (100.0) | |
| 6a | 0 (0.0) | 18 (100.0) | |
| 6b | 0 (0.0) | 7 (0.0) | |
| 7 | 0 (0.0) | 0 (0.0) |
a
RIF, rifampin; INH, isoniazid; EMB, ethambutol; STR, streptomycin.